AKT1 and neoplasm: Signaling pathways downstream Gas6/AXL signaling, including PI3K/AKT/mTOR, NF-κB, JAK/STAT3 and RAS/RAF/MEK/ERK, play critical roles in tumor cell cycle regulation, malignancy and drug resistance (14–17).